Showing results (111-120 of 277) with videos related to
Sort By:
Pageof 28
NMR in Biomedicine|February 24, 2026
Patient-Specific Biases in Fat Fraction Estimates of Malignant Bone Marrow due to Relaxation Times Measured With STEAM at 3TYassine N Azma, David J Collins, Pete J Lally, et al.Anticancer Research|November 10, 2019
Imaging Soft-tissue Sarcomas of the Head and Neck: A Tertiary Soft-tissue Sarcoma Unit ExperienceAlaa Alsadik Jaly, Khin Thway, Philip Touska, et al.Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 1, 2021
Radiomics in Oncology: A Practical GuideJoshua D Shur, Simon J Doran, Santosh Kumar, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 10, 2021
Gastrointestinal leiomyosarcoma demonstrate a predilection for distant recurrence and poor response to systemic treatmentsAlannah Smrke, Charlotte Benson, Dirk C Strauss, et al.Sarcoma|April 11, 2022
Prognostic Significance of Bone Metastasis in Soft Tissue Sarcoma Patients Receiving Palliative Systemic Therapy: An Explorative, Retrospective Pooled Analysis of the EORTC-Soft Tissue and Bone Sarcoma Group (STBSG) DatabaseGeorgios Kantidakis, Saskia Litière, Hans Gelderblom, et al.Medical Oncology (Northwood, London, England)|September 7, 2018
Clinical Characteristics and efficacy of chemotherapy in sclerosing epithelioid fibrosarcomaWinston Chew, Charlotte Benson, Khin Thway, et al.Physics in Medicine and Biology|October 30, 2025
AI-driven software for automated quantification of skeletal metastases and treatment response evaluation using whole-body diffusion-weighted MRI (WB-DWI) in advanced prostate cancerAntonio Candito, Matthew D Blackledge, Richard Holbrey, et al.British Journal of Haematology|June 27, 2007
Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of p38 MAPKMonica Hecht, Ulrike Heider, Martin Kaiser, et al.Clinical Lymphoma, Myeloma & Leukemia|April 8, 2010
Decrease in CD4+ T-cell counts in patients with multiple myeloma treated with bortezomibUlrike Heider, Jessica Rademacher, Martin Kaiser, et al.Biochemical and Biophysical Research Communications|October 12, 2005
Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone diseaseUlrike Heider, Lorenz C Hofbauer, Ivana Zavrski, et al.Pageof 28